REQUEST A DEMO
Total
USD $0.00
Search more companies

Neurodiagnostika Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Neurodiagnostika Sas Profile Updated: May 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Neurodiagnostika Sas is based in Colombia, with the head office in Cali. The enterprise currently operates in the Ambulatory Health Care Services sector. The enterprise was incorporated on April 08, 2018. 1 (2025) employees currently work for Neurodiagnostika Sas. In its most recent financial highlights, the company reported a net sales revenue increase of 31.66% in 2025. Over the same period, its total assets decreased by 19.8%. The net profit margin of Neurodiagnostika Sas decreased by 32.38% in 2025.

Headquarters
Cl 6 # 39 - 25 Ed Centro Empresa Cu 1005 1006
Cali; Valle del Cauca;

Contact Details: Purchase the Neurodiagnostika Sas report to view the information.

Basic Information
Total Employees:
Purchase the Neurodiagnostika Sas report to view the information.
Registered Capital:
Purchase the Neurodiagnostika Sas report to view the information.
Financial Auditors:
Purchase the Neurodiagnostika Sas report to view the information.
Incorporation Date:
April 08, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Neurodiagnostika Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.66%
Total Operating Revenue
31.66%
Operating Profit
-79.12%
EBITDA
-80.22%
Net Profit/Loss for the Period
-76.49%
Total Assets
-19.8%
Total Equity
10.65%
Operating Profit Margin
-37.34%
Net Profit Margin
-32.38%
Return on Equity (ROE)
-35.67%
Quick Ratio
5.77%
Cash Ratio
0.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?